Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Oncology Today with Dr Neil Love
00:00
Exploring New Frontiers in Lung Cancer Treatment: CRS and ADCs
This chapter explores oncologists' insights on managing cytokine release syndrome (CRS) and neurological issues linked to therapies like tarlatumab. It also discusses the potential for outpatient treatment models and the future of antibody-drug conjugates (ADCs) in targeting lung cancer.
Transcript
Play full episode
